Form D · Biotechnology

GRI BIO, Inc.

La Jolla, CA · CIK 0001824293

Offering snapshot reported Oct 25, 2024 · SEC filing

Reported sold
$762K
Offering amount: $762K
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 21, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 25, 2024Initial$762,236No comparison3SEC filing
Apr 27, 2023Initial$15,583,333No comparison1SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$61K
Finders' fees
$0
Form D file number
021-527895
The Company also issued to H.C. Wainwright & Co., LLC or its designees warrants to purchase up to 53,357 shares of common stock that are immediately exercisable with a five-year term from the issuance date and a $1.25 per share exercise price.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
H.C. Wainwright & Co., LLC375

Source: Form D, filed Oct 25, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Albert Argo Director, Executive
David Baker Director
Vipin Kumar Chaturvedi Director, Executive
Walter Marc Hertz Director, Executive
Leanne Kelly Executive
Roelof Rongen Director
Camilla Simpson Director
David Szekeres Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2223 Avenida De La Playa Suite 208
La Jolla, CA, 92037